Get startedLog in
    Picture of Travere Therapeutics logo

    TVTX — Travere Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Travere Therapeutics Q4 EPS USD -0.73 Vs. IBES Estimate USD -0.56

    Picture of Travere Therapeutics logoTravere Therapeutics
    20/02/2025 21:01
    Feb 20 (Reuters) - Travere Therapeutics Q4 product sales USD 73.546 million
vs. IBES estimate USD 73.3 million.
* Q4 operating income USD -60.737 million vs. IBES estimate USD -47 million
* Q4 net income USD -60.264 million
* Q4 operating expenses USD 135.524 million

    Recent news on Travere Therapeutics

    See all news